Patents by Inventor Mark J. Pieloch

Mark J. Pieloch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of use and dosage composition of bluegreen algae extract for inflammation in animals
    Patent number: 7025965
    Abstract: A means and method for treating inflammation and pain in animals is described. The compounds include phycocyanin in a pharmaceutically acceptable carrier. Phycocyanin has been found to be a COX-2 selective agent, and therefore alleviates pain and inflammation without the side effects that occur with NSAIDs that are not COX-2 selective.
    Type: Grant
    Filed: February 12, 2003
    Date of Patent: April 11, 2006
    Assignee: Pharma Chemie, Inc.
    Inventor: Mark J. Pieloch
  • Coated potassium chloride granules and tablets
    Patent number: 6780437
    Abstract: This invention provides extended release potassium chloride granules consisting essentially of potassium chloride crystals having a mesh size of about 20-60 mesh that are coated only with ethylcellulose. The granules may be compressed into tablets that disintegrate rapidly in an aqueous environment to provide uniform dissolution of the potassium chloride. Tablets containing about 10 to about 20 milliequivalents potassium may be formulated in accordance with the invention. Processes to produce extended release granules without using surfactants, processing aids or other coating aids are also provided by this invention. A method is further provided whereby a patient's supplemental potassium requirements are met by administering an appropriate combination of dosage units chosen from available dosage units containing different quantities of potassium.
    Type: Grant
    Filed: February 14, 2002
    Date of Patent: August 24, 2004
    Assignee: Upsher-Smith Laboratories, Inc.
    Inventors: Bradley L. Christenson, Mark J. Pieloch
  • Coated potassium chloride granules and tablets
    Publication number: 20030104071
    Abstract: This invention provides extended release potassium chloride granules consisting essentially of potassium chloride crystals having a mesh size of about 20-60 mesh that are coated only with ethylcellulose. The granules may be compressed into tablets that disintegrate rapidly in an aqueous environment to provide uniform dissolution of the potassium chloride. Tablets containing about 10 to about 20 milliequivalents potassium may be formulated in accordance with the invention. Processes to produce extended release granules without using surfactants, processing aids or other coating aids are also provided by this invention. A method is further provided whereby a patient's supplemental potassium requirements are met by administering an appropriate combination of dosage units chosen from available dosage units containing different quantities of potassium.
    Type: Application
    Filed: February 14, 2002
    Publication date: June 5, 2003
    Inventors: Bradley L. Christenson, Mark J. Pieloch
  • Coated potassium chloride granules and tablets
    Publication number: 20030104070
    Abstract: This invention provides extended release potassium chloride granules consisting essentially of potassium chloride crystals having a mesh size of about 20-60 mesh that are coated only with ethylcellulose. The granules may be compressed into tablets that disintegrate rapidly in an aqueous environment to provide uniform dissolution of the potassium chloride. Processes to produce extended release granules without using surfactants, processing aids or other coating aids are also provided by this invention.
    Type: Application
    Filed: October 23, 2001
    Publication date: June 5, 2003
    Inventors: Bradley L. Christenson, Mark J. Pieloch